Latest News

UPCOMING NEUROSENS WEBINAR – MAY 20, 2025

May 6, 2025  

Join us for the next event in the NeuroSens Webinar Series:

EPILEPSY MANAGEMENT 2025:  USE OF ADJUNCTIVE THERAPIES IN PRACTICE
Tuesday, May 20th, 2025 – 7:00-8:00 PM EDT

Guest speaker, Dr. Pavel Klein will review the optimal use of adjunctive antiseizure medications in the management of focal epilepsy and provides a practical guide on dose adjustments of concomitant treatments.

CLICK HERE TO REGISTER
or email Kate Stella at kast@lind-pub.com

Dr. Pavel Klein is Director of the Mid-Atlantic Epilepsy and Sleep Center in Bethesda, Maryland and Clinical Professor of Neurology at The George Washington University, Washington, DC. A graduate of Cambridge University, UK, Dr. Klein is the former Director of the Epilepsy Center, the Clinical Neurophysiology Laboratory and of the Neuroendocrinology Unit at Georgetown University Hospital. His research interests include novel pharmacologic and dietary treatments for epilepsy, and epilepsy prevention following traumatic brain injury.

WHO SHOULD ATTEND: General and specialist Canadian neurologists with an interest in epilepsy.

 

Treatment discontinuation in MS: the DOT-MS trial

May 5, 2025  

The newly-published Discontinuing Disease-modifying Therapies in Stable Relapsing-onset Multiple Sclerosis (DOT-MS) is the second important trial to examine the feasibility of discontinuing disease-modifying therapy (DMT) in patients with multiple sclerosis (Coerver et al. JAMA Neurol 2025;82:123-131). Read More

TOPICS:

CLINICAL CASES IN MS: A 24 Y.O. WOMAN WITH PARESTHESIAE AND NON-ENHANCING LESIONS

April 25, 2025  

Click here to complete the interactive survey.
Once you submit your responses, you will be able to view all of your colleagues’ responses.

R.M. is a 24-year-old woman who works at a daycare centre. She is referred from the emergency room because of a two-week history of paresthesiae in both legs and the mid and lower trunk. She is not aware of any weakness. There is no bladder disturbance. She has a subjective mid truncal sensory level. Prior history includes a Bell’s palsy three years ago which was painless and resolved without treatment in 3-4 weeks. Read More